Denver jury acquits DaVita, former CEO, of all charges in antitrust trial -

After two days of deliberations, a Denver jury found DaVita and former CEO Kent Thiry not guilty of all charges relating to charges they conspired with competitors not to hire each other’s senior managers. The Department of Justice argued the dialysis provider’s nonpoaching agreement violated the Sherman Anti-trust Act and considered DaVita a test case ahead of other possible criminal charges in similar instances. If convicted, DaVita was facing a maximum penalty of a $100 million fine on each of three counts, while Thiry could’ve been fined $1 million on each of three charges and sent to prison for up to 10 years.